100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes. (2021)
Attributed to:
The role of type 2 innate lymphoid cells in autoimmune islet infiltration and diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/immadv/ltab024
PubMed Identifier: 35156097
Publication URI: http://europepmc.org/abstract/MED/35156097
Type: Journal Article/Review
Volume: 1
Parent Publication: Immunotherapy advances
Issue: 1
ISSN: 2732-4303